Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  New England Journal of Medicine

• Publication date

  2001-03-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM200103293441304PMID 11274623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.

  2000cited by this paper
• Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

  2000cited by this paper
• Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.

  1999cited by this paper
• Helicobacter pylori and non-steroidal anti-inflammatory drugs: ulcers and bleeding ulcers.

  1999cited by this paper
• Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

  1999cited by this paper
• A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Anti-inflammatory Drugs

  1999cited by this paper
• Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

  1999cited by this paper
• Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users

  1999influential reference
• Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed.

  1999cited by this paper
• Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole

  1999cited by this paper
• Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.

  1998cited by this paper
• Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

  1998cited by this paper
• Eradication of H. Pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: A prospective randomizd study

  1998cited by this paper
• A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

  1998cited by this paper
• Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?

  1998cited by this paper
• Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

  1997cited by this paper
• Peptic ulcer bleeding in the elderly: relative roles ofHelicobacter pylori and non-steroidal anti-inflammatory drugs

  1997cited by this paper
• Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

  1996cited by this paper
• Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.

  1996cited by this paper
• Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.

  1996cited by this paper
• Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.

  1996cited by this paper
• Prophylactic aspirin and risk of peptic ulcer bleeding

  1995cited by this paper
• Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.

  1992cited by this paper
• A multiple testing procedure for clinical trials.

  1979influential reference
• Regression Models and Life-Tables

  1972influential reference

• Eradication of Helicobacter pylori for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT.

  2025cites this paper
• Reply to ‘Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease’

  2024cites this paper
• Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)

  2024cites this paper
• Peptic ulcer disease.

  2024cites this paper
• Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy

  2023cites this paper
• Comparison of the Frequency of Gastrointestinal Bleeding Complications Resulting from the use of Ketorolac after Gastrointestinal Cancer Surgery with or without Gastric Ulcer Prophylaxis - A Case Control Study

  2023cites this paper
• Helicobacter pylori eradication as a gastroprotective strategy in elderly aspirin-treated subjects: established facts and unanswered questions.

  2023cites this paper
• Peptic ulcer.

  2023cites this paper
• Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study

  2023cites this paper
• Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001

  2022cites this paper
• Resumption of Antiplatelet Therapy after Major Bleeding

  2022cites this paper
• Aspirin and Helicobacter pylori interaction.

  2022cites this paper
• Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 th September 2017, Charité, Berlin

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

  2022cites this paper
• The Evolution of Gastrointestinal Bleeding: A Holistic Investigation of Global Outputs with Bibliometric Analysis

  2022cites this paper
• The relationship between climate change, health, and the humanitarian response

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• Low-dose aspirin for the prevention of atherothrombosis across the cardiovascular risk continuum

  2022cites this paper
• Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.

  2022cites this paper
• PPI co-therapy and gastrointestinal bleeding with antithrombotic drugs: A step forward but not enough.

  2021cites this paper
• Towards personalised management for non-variceal upper gastrointestinal bleeding

  2021cites this paper
• Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology

  2021cites this paper
• Evidence-based clinical practice guidelines for peptic ulcer disease 2020

  2021cites this paper
• The influence of the acetylsalicylic acid and its complex compounds with metals on the morphometric characteristics of the stomach mucous membrane

  2021cites this paper
• Global Trends of Publication of Randomized Controlled Trials of Helicobacter Pylori Research

  2021cites this paper
• Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding

  2020cites this paper
• Toxicité gastroduodénale des médicaments anti-inflammatoires non stéroïdiens

  2020cites this paper
• 아스피린 및 항혈소판제 관련 소화성궤양의 예방

  2020cites this paper
• 약제 연관 소화성궤양의 임상 진료지침 개정안 2020

  2020cites this paper
• Hellenic consensus on Helicobacter pylori infection

  2020cites this paper
• Clinical Guidelines for Drug-Related Peptic Ulcer, 2020 Revised Edition

  2020influential citation
• 약제 유발 소화성궤양과 헬리코박터 제균 치료

  2020cites this paper
• Role of Camphlobacter pylori and non steroidal anti-inflammatory drugs in the pathogenesis of peptic ulcer and pharmacological approaches for the treatment of peptic ulcer disease

  2019cites this paper
• Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group

  2019cites this paper
• Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs

  2019cites this paper
• Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users

  2019cites this paper
• Clinical Therapeutics in Hong Kong

  2019cites this paper
• The promising role of hydrogel in reducing the acidic effects of aspirin in human stomach

  2019cites this paper
• Proton pump inhibitors and hypomagnesemia

  2019cites this paper
• Preventing recurrent stroke and other serious vascular events

  2019cites this paper
• Inpatient Outcomes for Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention

  2019cites this paper
• Nonsteroidal Anti-Inflammatory Drug-Gastropathy and Enteropathy

  2019cites this paper
• Role of Helicobacter pylori in Upper Gastrointestinal Bleeding Among Ischemic Stroke Hospitalizations: A Nationwide Study of Outcomes

  2019cites this paper
• Diagnostic approach & pharmacological treatment regimen of Peptic Ulcer Disease

  2019cites this paper
• The Clinician’s Guide to Proton-Pump Inhibitor Discontinuation

  2019cites this paper
• Effect of Hydrotalcite on Indometacin-Induced Gastric Injury in Rats

  2019cites this paper
• JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

  2019cites this paper
• A Study on the Status of Proton Pump Inhibitor Prescriptions Using Diagnosis Procedure Combination Data in Japan

  2019cites this paper
• Functional Dyspepsia in the Elderly

  2019cites this paper
• Can Helicobacter pylori Infection Accelerate the Healing of Nonsteroidal Anti-inflammatory Drugs-induced Peptic Ulcer and Bleeding?

  2019cites this paper
• The rise and fall of aspirin in the primary prevention of cardiovascular disease.

  2019cites this paper
• Helicobacter pylori management in ASEAN: The Bangkok consensus report

  2018cites this paper
• Non-variceal upper gastrointestinal bleeding

  2018cites this paper
• Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti‐inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors

  2018cites this paper
• Antiplatelet treatment and gastro-intestinal hemorrhage risk

  2018cites this paper
• Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin

  2018cites this paper
• Nonsteroidal anti-inflammatory drugs and cancer pain

  2018cites this paper
• Non-variceal upper GI bleeding

  2018cites this paper
• Helicobacter pylori infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta‐analysis

  2018cites this paper
• Risk Factors for Gastrointestinal Injuries in Acute Coronary Syndrome Patients with Double Antiplatelet Therapy in One-Year Follow-Up

  2018cites this paper
• The Role of Helicobacter pylori Infection in Drug-induced Peptic Ulcer

  2018cites this paper
• geschützt werden ? NSAIDs , Coxibs and Steroids : When and How to Protect the Stomach and Intestine

  2018cites this paper
• Helicobacter pylori infection diagnostics and choice of eradication treatment: results of inquiry of doctors from different regions of Russian Federation

  2018cites this paper
• Increased susceptibility of aging gastric mucosa to injury and delayed healing: Clinical implications

  2018cites this paper
• Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.

  2018cites this paper
• The fourth Mexican consensus on Helicobacter pylori.

  2018cites this paper
• Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.

  2017cites this paper
• Gastrointestinal bleeding in patients with renal failure under hemodialysis treatment: a single-center experience

  2017cites this paper
• Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers

  2017cites this paper
• The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.

  2017cites this paper
• Management of Helicobacter pylori Infection.

  2017cites this paper
• Toxicité gastroduodénale des médicaments anti-inflammatoires non stéroïdiens

  2017cites this paper
• Errata: NSAR, Coxibe und Steroide: Wann und wie sollten Magen und Darm geschützt werden?

  2017cites this paper
• Incidence of Major Gastrointestinal Bleeding in Patients with Acute Coronary Syndrome Treated with Dual Antiplatelet and Anticoagulant Therapy-Data from the Registry

  2017cites this paper
• NSAR, Coxibe und Steroide: Wann und wie sollten Magen und Darm geschützt werden?

  2017cites this paper
• No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents

  2017cites this paper
• Assessment of platelet activation and prothrombotic risk following acute upper gastrointestinal bleeding and bleeding in the context of acute coronary syndromes

  2017cites this paper
• Long-Term PPI Use: Balancing Potential Harms and Documented Benefits

  2016cites this paper
• In silico characterization of ferritin-1 chloroplast targeting peptide encoding sequence in chickpea and pigeonpea Poornima

  2016cites this paper
• Adverse Effects of NSAIDs in the Gastrointestinal Tract: Risk Factors of Gastrointestinal Toxicity with NSAIDs

  2016cites this paper
• Evidence-based clinical practice guidelines for peptic ulcer disease 2015

  2016cites this paper
• Efficacy of Proton-Pump Inhibitors vs H 2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-risk Users of Low-dose Aspirin

  2016cites this paper
• Management of NSAID-associated peptic ulcer disease

  2016cites this paper
• [Peptic Ulcer Disease Associated with Helicobacter pylori Infection].

  2016cites this paper
• Helicobacter pylori screening: options and challenges

  2016influential citation
• Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

  2016cites this paper
• Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study

  2016cites this paper
• [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

  2016cites this paper
• focu “ It is estimated that more than 50 % of the world ’ s population is infected with H . pylori ”

  2016cites this paper
• Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drugassociated erosions and ulcers?

  2016cites this paper
• Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial

  2016cites this paper
• Aspirin and the Prevention of Colorectal Cancer

  2016cites this paper
• Safe Prescription of NSAIDs in Clinical Practice

  2016cites this paper
• Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection

  2016cites this paper
• Aspirin in the Treatment and Prevention of Cardiovascular Disease: Need for Individual Clinical Judgments

  2016cites this paper
• NSAID-Induced Gastropathy and H. pylori Infection

  2016cites this paper
• Approach to Suspected Nonvariceal Upper Gastrointestinal Bleeding

  2016cites this paper
• S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease

  2016cites this paper
• Ulkuskrankheit – Update

  2016cites this paper
• Gastroprotection with proton-pump inhibitors in high-risk cardiovascular patients: who to target and for how long?

  2016cites this paper